Treatment of bleeding oesophageal varices with somatostatin. 1979

L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić

Cyclic somatostatin was administered intravenously on eight occasions to five consecutive patients with massive haemalemesis due to oesophageal varices. The doses administered with 0--250 micrograms as bolus, followed by 100--250 micrograms per hr during 2--12 hrs. The source of bleeding was determined by endoscopy. The volume of bleeding was estimated from the clinical condition of the patient and by gastric irrigation and iced water. The bleeding stopped immediately on all occasions when somatostatin was administered. It is suggested that the effect is due to the ability of somatostatin to reduce regional splanchnic blood flows and portal pressure.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D005260 Female Females
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
January 1990, Acta gastro-enterologica Belgica,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
January 2005, The Cochrane database of systematic reviews,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
July 2008, The Cochrane database of systematic reviews,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
January 2002, The Cochrane database of systematic reviews,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
January 2000, The Cochrane database of systematic reviews,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
January 1992, Drugs,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
February 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
June 1971, Lancet (London, England),
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
October 1986, Scandinavian journal of gastroenterology,
L Thulin, and G Tydén, and H Samnegård, and O Muhrbeck, and S Efendić
June 2000, Bailliere's best practice & research. Clinical gastroenterology,
Copied contents to your clipboard!